List of Flovent Hfa drug patents

Flovent Hfa is owned by Glaxo Grp Ltd.

Flovent Hfa contains Fluticasone Propionate.

Flovent Hfa has a total of 4 drug patents out of which 0 drug patents have expired.

Flovent Hfa was authorised for market use on 14 May, 2004.

Flovent Hfa is available in aerosol, metered;inhalation dosage forms.

The generics of Flovent Hfa are possible to be released after 26 August, 2026.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7832351 GLAXO GRP LTD Actuation indicator for a dispensing device
Jun, 2023

(2 months from now)

US7832351

(Pediatric)

GLAXO GRP LTD Actuation indicator for a dispensing device
Dec, 2023

(8 months from now)

US7500444 GLAXO GRP LTD Actuation indicator for a dispensing device
Feb, 2026

(2 years from now)

US7500444

(Pediatric)

GLAXO GRP LTD Actuation indicator for a dispensing device
Aug, 2026

(3 years from now)

Drugs and Companies using FLUTICASONE PROPIONATE ingredient

Market Authorisation Date: 14 May, 2004

Treatment: NA

Dosage: AEROSOL, METERED;INHALATION

How can I launch a generic of FLOVENT HFA before it's patent expiration?
More Information on Dosage

FLOVENT HFA family patents

3

European Union

2

Portugal

2

United Kingdom

2

Hong Kong

2

United States

2

Denmark

2

Spain

2

Japan

2

China

2

Cyprus

1

Germany

1

Austria

1

Australia

1

Brazil

1

Canada

1

Mexico

1

South Africa

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic